BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15952087)

  • 1. Pentosidine plasma levels and relation with metabolic control in diabetic patients.
    Lapolla A; Reitano R; Baccarin L; Sartore G; Plebani M; Fedele D
    Horm Metab Res; 2005 Apr; 37(4):252-6. PubMed ID: 15952087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of n-3 long-chain polyunsaturated fatty acid supplementation on AGEs and sRAGE in type 2 diabetes mellitus.
    Kurt A; Andican G; Siva ZO; Andican A; Burcak G
    J Physiol Biochem; 2016 Dec; 72(4):679-687. PubMed ID: 27448155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
    Hirata K; Kubo K
    Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
    Ghanem AA; Elewa A; Arafa LF
    Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN).
    Schiel R; Franke S; Appel T; Voigt U; Ross IS; Kientsch-Engel R; Stein G; Müller UA
    J Diabetes Complications; 2003; 17(2):90-7. PubMed ID: 12614975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress.
    Lapolla A; Reitano R; Seraglia R; Sartore G; Ragazzi E; Traldi P
    Mol Nutr Food Res; 2005 Jul; 49(7):685-90. PubMed ID: 15926142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metformin and pioglitazone on serum pentosidine levels in type 2 diabetes mellitus.
    Kanazawa I; Yamamoto M; Yamaguchi T; Sugimoto T
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):362-5. PubMed ID: 21472665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between plasma pentosidine concentrations and retinal hemodynamics in patients with type 2 diabetes.
    Sato E; Nagaoka T; Yokota H; Takahashi A; Yoshida A
    Am J Ophthalmol; 2012 May; 153(5):903-909.e1. PubMed ID: 22265156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Esmaeili F; Maleki V; Kheirouri S; Alizadeh M
    Can J Diabetes; 2021 Feb; 45(1):39-46. PubMed ID: 32861603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
    Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y
    Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor-α levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial.
    Houjeghani S; Kheirouri S; Faraji E; Jafarabadi MA
    Nutr Res; 2018 Jan; 49():96-106. PubMed ID: 29420997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy.
    Daimon M; Ono Y; Saito T; Yamaguchi H; Hirata A; Ohnuma H; Igarashi M; Eguchi H; Manaka H; Kato T
    Diabetes Care; 1999 May; 22(5):877-8. PubMed ID: 10332715
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
    Sugiyama S; Miyata T; Ueda Y; Tanaka H; Maeda K; Kawashima S; Van Ypersele de Strihou C; Kurokawa K
    J Am Soc Nephrol; 1998 Sep; 9(9):1681-8. PubMed ID: 9727377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes.
    Barzilay JI; Jablonski KA; Fonseca V; Shoelson SE; Goldfine AB; Strauch C; Monnier VM;
    Diabetes Care; 2014 Apr; 37(4):1083-91. PubMed ID: 24255104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus.
    Smulders RA; Stehouwer CD; Schalkwijk CG; Donker AJ; van Hinsbergh VW; TeKoppele JM
    Thromb Haemost; 1998 Jul; 80(1):52-7. PubMed ID: 9684785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentosidine - a new biochemical marker in diabetic retinopathy.
    Salman AG; Mansour DE; Swelem AH; Al-Zawahary WM; Radwan AA
    Ophthalmic Res; 2009; 42(2):96-8. PubMed ID: 19546600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.
    Haddad M; Knani I; Bouzidi H; Berriche O; Hammami M; Kerkeni M
    Dis Markers; 2016; 2016():6248264. PubMed ID: 27829696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control.
    Neumann T; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Sämann A
    Osteoporos Int; 2014 May; 25(5):1527-33. PubMed ID: 24599273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the albumin glycation site, plasma pentosidine and esRAGE concentrations before and after intensive diabetic treatment in patients with abnormally high glycated albumin levels.
    Miyamoto H; Kohzuma T; Ohnishi A
    Ann Clin Biochem; 2018 Jan; 55(1):84-91. PubMed ID: 28504612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
    Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.